Synthesis shows reversible transformations of sulfoxides into hypervalent species in solution, suggesting new synthesis methods.
The preparation of the novel optically active sulfoxides (-)-(S)-1,1,1,3,3,3-hexafluoro-2-[o-(p-tolylsulfinyl)phenyl]propan-2-ol 1, (-)-(S)-1,1,1,3,3,3-hexafluoro-2-[o-(methylsulfinyl)phenyl]propan-2-ol 2 and (-)-(S)-1,1,1,3,3,3-hexafluoro-2-[o-(t-butyl-sulfinyl)phenyl]propan-2-ol 3 according to the Andersen methodology and their spectroscopic characterization is presented. The NMR and CD spectroscopic evidence of the existence of the equilibrium between sulfoxide and hypervalent sulfurane forms of these compounds in solution and attempts at the isolation of corresponding sulfuranes are shown. For compound 3, the unprecedented subsequent irreversible transformation in solution into corresponding cyclic sulfinate ester–sultine 17 was established on the basis of NMR spectroscopy measurements. The mechanism of this transformation was investigated by means of GC-MS analysis and confirmed on the basis of synthesized long alkyl chain analog 23 transformation in solution. Moreover, the oxidation properties of obtained sulfoxides 2 and 3 for the selected compounds are described.
No takes yet. Share an insight, caveat, or question.
Zajac et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: